Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/25510
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2022-04-01T08:07:37Z-
dc.date.available2022-04-01T08:07:37Z-
dc.date.issued2012-09-
dc.identifier.citationAyarcı, A. O. vd. (2012). "Diagnostic value of serum high mobility group box protein 1 (HMGB1) and soluble CD163 (sCD163) levels in brucellosis". Immunology, 137(Supplement 1), Special Issue, 669-670.en_US
dc.identifier.issn0019-2805-
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458242/pdf/imm0137-0185.pdf-
dc.identifier.urihttp://hdl.handle.net/11452/25510-
dc.descriptionBu çalışma, 05-08Eylül 2012 tarihleri arasında Glasgow[İskoçya]’da düzenlenen European Congress of Immunology’da bildiri olarak sunulmuştur.tr_TR
dc.description.abstractBoth CD4+ and CD8+ T lymphocytes play critical roles in immunity to Brucella, in part because they secrete IFN-c and activate the bactericidal functions in macrophages. Therefore, use of markers which can evaluate macrophage activation may have diagnostic and prognostic importance. High mobility group-box 1 protein (HMGB1) is a late-onset proinflammatory cytokine secreted from activated macrophages. Soluble hemoglobin scavenger receptor (sCD163) is a specific marker of antiinflammatory macrophages. The aim of this study was to test potential associations of serum levels of HMGB1 and sCD163 with Brucellosis and its acute, subacute and chronic formsen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectImmunologyen_US
dc.titleDiagnostic value of serum high mobility group box protein 1 (HMGB1) and soluble CD163 (sCD163) levels in brucellosisen_US
dc.typeMeeting Abstracten_US
dc.identifier.wos000309189106022tr_TR
dc.relation.publicationcategoryKonferans Öğesi - Uluslararasıtr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi.tr_TR
dc.contributor.orcid0000-0003-0463-6818tr_TR
dc.identifier.startpage669tr_TR
dc.identifier.endpage670tr_TR
dc.identifier.volume137tr_TR
dc.identifier.issueSupplement 1, Special Issueen_US
dc.relation.journalImmunologyen_US
dc.contributor.buuauthorAyarcı, Ayşe Oǧuz-
dc.contributor.buuauthorYılmaz, Emel-
dc.contributor.buuauthorSığırlı, Deniz-
dc.contributor.buuauthorBudak, Ferah-
dc.contributor.buuauthorGöral, Güher-
dc.contributor.buuauthorOral, Haluk Barbaros-
dc.contributor.researcheridF-4657-2014tr_TR
dc.contributor.researcheridAAA-7472-2021tr_TR
dc.contributor.researcheridK-7285-2012tr_TR
dc.subject.wosImmunologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.wosCPCISen_US
dc.wos.quartileQ2en_US
Appears in Collections:Web of Science

Files in This Item:
File Description SizeFormat 
Ayarcı_vd_2012.pdf5.63 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons